APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptives

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Selected research

Market Structure

Global Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025198 pages

Choose your research edition.

Industry ResearchContraceptives Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptives Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Contraceptives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptives Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptives Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.

Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.

The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.

Read the full market overview

This report provides an overview of the global Contraceptives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Contraceptives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Contraceptives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Contraceptives market size, projected growth trends, production technologies, key applications, and end-use industries.

Contraceptives Segment by Company

Bayer AG

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

Merck & Co., Inc

Actavis, Inc.

Johnson & Johnson

Gedeon Richter

Novo Nordisk A/S

ZiZhu

Baijingyu

Huazhong

Sine

Reckitt

AbbVie

Church & Dwight

The Cooper Companies

TherapeuticsMD

Afaxys

Mithra Pharmaceuticals

Contraceptives Segment by Type

Pills

Injectable

Condoms

Vaginal Rings

IUDs

Subdermal Implants

Others

Contraceptives Segment by End User

15–24 years

25–34 years

35–44 years

Above 44 years

Contraceptives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Contraceptives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Contraceptives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Contraceptives Industry Trends Table 2. Contraceptives Industry Drivers Table 3. Contraceptives Industry Opportunities and Challenges Table 4. Contraceptives Industry Restraints Table 5. Global Contraceptives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Contraceptives Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Contraceptives Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Contraceptives Sales Market Share by Manufacturers Table 9. Global Contraceptives Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Contraceptives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Contraceptives Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Contraceptives Manufacturers, Product Type & Application Table 13. Global Contraceptives Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Contraceptives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pills Table 17. Major Manufacturers of Injectable Table 18. Major Manufacturers of Condoms Table 19. Major Manufacturers of Vaginal Rings Table 20. Major Manufacturers of IUDs Table 21. Major Manufacturers of Subdermal Implants Table 22. Major Manufacturers of Others Table 23. Global Contraceptives Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 24. Global Contraceptives Sales by Type (2021-2026) & (M Units) Table 25. Global Contraceptives Sales by Type (2027-2032) & (M Units) Table 26. Global Contraceptives Sales Market Share by Type (2021-2026) Table 27. Global Contraceptives Sales Market Share by Type (2027-2032) Table 28. Global Contraceptives Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 29. Global Contraceptives Revenue by Type (2021-2026) & (M Units) Table 30. Global Contraceptives Revenue by Type (2027-2032) & (M Units) Table 31. Global Contraceptives Revenue Market Share by Type (2021-2026) Table 32. Global Contraceptives Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of 15–24 years Table 34. Major Manufacturers of 25–34 years Table 35. Major Manufacturers of 35–44 years Table 36. Major Manufacturers of Above 44 years Table 37. Global Contraceptives Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 38. Global Contraceptives Sales by Application (2021-2026) & (M Units) Table 39. Global Contraceptives Sales by Application (2027-2032) & (M Units) Table 40. Global Contraceptives Sales Market Share by Application (2021-2026) Table 41. Global Contraceptives Sales Market Share by Application (2027-2032) Table 42. Global Contraceptives Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 43. Global Contraceptives Revenue by Application (2021-2026) & (M Units) Table 44. Global Contraceptives Revenue by Application (2027-2032) & (M Units) Table 45. Global Contraceptives Revenue Market Share by Application (2021-2026) Table 46. Global Contraceptives Revenue Market Share by Application (2027-2032) Table 47. Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 48. Global Contraceptives Sales by Region (2021-2026) & (M Units) Table 49. Global Contraceptives Sales Market Share by Region (2021-2026) Table 50. Global Contraceptives Sales Forecasted by Region (2027-2032) & (M Units) Table 51. Global Contraceptives Sales Forecasted Market Share by Region (2027-2032) Table 52. North America Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. North America Contraceptives Sales by Country (2021-2026) & (M Units) Table 54. North America Contraceptives Sales by Country (2027-2032) & (M Units) Table 55. Europe Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Europe Contraceptives Sales by Country (2021-2026) & (M Units) Table 57. Europe Contraceptives Sales by Country (2027-2032) & (M Units) Table 58. Asia Pacific Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. Asia Pacific Contraceptives Sales by Country (2021-2026) & (M Units) Table 60. Asia Pacific Contraceptives Sales by Country (2027-2032) & (M Units) Table 61. South America, Middle East and Africa Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 62. South America, Middle East and Africa Contraceptives Sales by Country (2021-2026) & (M Units) Table 63. South America, Middle East and Africa Contraceptives Sales by Country (2027-2032) & (M Units) Table 64. Global Contraceptives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 65. Global Contraceptives Revenue by Region (2021-2026) & (US$ Million) Table 66. Global Contraceptives Revenue by Region (2027-2032) & (US$ Million) Table 67. Global Contraceptives Revenue Market Share by Region (2021-2026) Table 68. Global Contraceptives Revenue Market Share by Region (2027-2032) Table 69. Bayer AG Company Information Table 70. Bayer AG Business Overview Table 71. Bayer AG Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Bayer AG Contraceptives Product Portfolio Table 73. Bayer AG Recent Development Table 74. Pfizer, Inc Company Information Table 75. Pfizer, Inc Business Overview Table 76. Pfizer, Inc Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer, Inc Contraceptives Product Portfolio Table 78. Pfizer, Inc Recent Development Table 79. Teva Pharmaceutical Industries Ltd Company Information Table 80. Teva Pharmaceutical Industries Ltd Business Overview Table 81. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio Table 83. Teva Pharmaceutical Industries Ltd Recent Development Table 84. Merck & Co., Inc Company Information Table 85. Merck & Co., Inc Business Overview Table 86. Merck & Co., Inc Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Merck & Co., Inc Contraceptives Product Portfolio Table 88. Merck & Co., Inc Recent Development Table 89. Actavis, Inc. Company Information Table 90. Actavis, Inc. Business Overview Table 91. Actavis, Inc. Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Actavis, Inc. Contraceptives Product Portfolio Table 93. Actavis, Inc. Recent Development Table 94. Johnson & Johnson Company Information Table 95. Johnson & Johnson Business Overview Table 96. Johnson & Johnson Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Johnson & Johnson Contraceptives Product Portfolio Table 98. Johnson & Johnson Recent Development Table 99. Gedeon Richter Company Information Table 100. Gedeon Richter Business Overview Table 101. Gedeon Richter Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Gedeon Richter Contraceptives Product Portfolio Table 103. Gedeon Richter Recent Development Table 104. Novo Nordisk A/S Company Information Table 105. Novo Nordisk A/S Business Overview Table 106. Novo Nordisk A/S Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Novo Nordisk A/S Contraceptives Product Portfolio Table 108. Novo Nordisk A/S Recent Development Table 109. ZiZhu Company Information Table 110. ZiZhu Business Overview Table 111. ZiZhu Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. ZiZhu Contraceptives Product Portfolio Table 113. ZiZhu Recent Development Table 114. Baijingyu Company Information Table 115. Baijingyu Business Overview Table 116. Baijingyu Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Baijingyu Contraceptives Product Portfolio Table 118. Baijingyu Recent Development Table 119. Huazhong Company Information Table 120. Huazhong Business Overview Table 121. Huazhong Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Huazhong Contraceptives Product Portfolio Table 123. Huazhong Recent Development Table 124. Sine Company Information Table 125. Sine Business Overview Table 126. Sine Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Sine Contraceptives Product Portfolio Table 128. Sine Recent Development Table 129. Reckitt Company Information Table 130. Reckitt Business Overview Table 131. Reckitt Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Reckitt Contraceptives Product Portfolio Table 133. Reckitt Recent Development Table 134. AbbVie Company Information Table 135. AbbVie Business Overview Table 136. AbbVie Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. AbbVie Contraceptives Product Portfolio Table 138. AbbVie Recent Development Table 139. Church & Dwight Company Information Table 140. Church & Dwight Business Overview Table 141. Church & Dwight Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Church & Dwight Contraceptives Product Portfolio Table 143. Church & Dwight Recent Development Table 144. The Cooper Companies Company Information Table 145. The Cooper Companies Business Overview Table 146. The Cooper Companies Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. The Cooper Companies Contraceptives Product Portfolio Table 148. The Cooper Companies Recent Development Table 149. TherapeuticsMD Company Information Table 150. TherapeuticsMD Business Overview Table 151. TherapeuticsMD Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. TherapeuticsMD Contraceptives Product Portfolio Table 153. TherapeuticsMD Recent Development Table 154. Afaxys Company Information Table 155. Afaxys Business Overview Table 156. Afaxys Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Afaxys Contraceptives Product Portfolio Table 158. Afaxys Recent Development Table 159. Mithra Pharmaceuticals Company Information Table 160. Mithra Pharmaceuticals Business Overview Table 161. Mithra Pharmaceuticals Contraceptives Sales (M Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Mithra Pharmaceuticals Contraceptives Product Portfolio Table 163. Mithra Pharmaceuticals Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Contraceptives Distributors List Table 167. Contraceptives Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Contraceptives Product Image Figure 2. Global Contraceptives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Contraceptives Market Size (2021-2032) & (US$ Million) Figure 4. Global Contraceptives Sales (2021-2032) & (M Units) Figure 5. Global Contraceptives Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pills Image Figure 9. Injectable Image Figure 10. Condoms Image Figure 11. Vaginal Rings Image Figure 12. IUDs Image Figure 13. Subdermal Implants Image Figure 14. Others Image Figure 15. Global Contraceptives Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 16. Global Contraceptives Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Contraceptives Sales Market Share by Type (2021-2032) Figure 18. Global Contraceptives Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 19. Global Contraceptives Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Contraceptives Revenue Market Share by Type (2021-2032) Figure 21. 15–24 years Image Figure 22. 25–34 years Image Figure 23. 35–44 years Image Figure 24. Above 44 years Image Figure 25. Global Contraceptives Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Contraceptives Sales Market Share 2021 VS 2025 VS 2032 Figure 27. Global Contraceptives Sales Market Share by Application (2021-2032) Figure 28. Global Contraceptives Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 29. Global Contraceptives Revenue Market Share 2021 VS 2025 VS 2032 Figure 30. Global Contraceptives Revenue Market Share by Application (2021-2032) Figure 31. North America Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 32. North America Contraceptives Sales Market Share by Country (2021-2032) Figure 33. U.S. Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Canada Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 35. Mexico Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 36. Europe Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 37. Europe Contraceptives Sales Market Share by Country (2021-2032) Figure 38. Germany Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 39. France Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 40. U.K. Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Italy Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 42. Netherlands Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Asia Pacific Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 44. Asia Pacific Contraceptives Sales Market Share by Country (2021-2032) Figure 45. China Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 46. Japan Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 47. South Korea Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 48. Southeast Asia Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 49. India Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 50. Australia Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South America, Middle East and Africa Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 52. South America, Middle East and Africa Contraceptives Sales Market Share by Country (2021-2032) Figure 53. Brazil Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 54. South Africa Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 55. Saudi Arabia Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Turkey Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Argentina Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 58. UAE Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 59. Egypt Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 60. Chile Contraceptives Sales and Growth Rate (2021-2032) & (M Units) Figure 61. Global Contraceptives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Global Contraceptives Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 63. North America Contraceptives Revenue (2021-2032) & (US$ Million) Figure 64. North America Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Europe Contraceptives Revenue (2021-2032) & (US$ Million) Figure 66. Europe Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Asia-Pacific Contraceptives Revenue (2021-2032) & (US$ Million) Figure 68. Asia-Pacific Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. South America, Middle East and Africa Contraceptives Revenue (2021-2032) & (US$ Million) Figure 70. South America, Middle East and Africa Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 71. Contraceptives Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Contraceptives Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Pills
  • Injectable
  • Condoms
  • Vaginal Rings
  • IUDs
  • Subdermal Implants
  • Others
Applications
  • 15–24 years
  • 25–34 years
  • 35–44 years
  • Above 44 years
Companies covered
  • Bayer AG
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • Merck & Co., Inc
  • Actavis, Inc.
  • Johnson & Johnson
  • Gedeon Richter
  • Novo Nordisk A/S
  • ZiZhu
  • Baijingyu
  • Huazhong
  • Sine
  • Reckitt
  • AbbVie
  • Church & Dwight
  • The Cooper Companies
  • TherapeuticsMD
  • Afaxys
  • Mithra Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Contraceptives Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Contraceptives Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Contraceptives Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Contraceptives Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Contraceptives Market Dynamics
  1. 2.1 Contraceptives Industry Trends
  2. 2.2 Contraceptives Industry Drivers
  3. 2.3 Contraceptives Industry Opportunities and Challenges
  4. 2.4 Contraceptives Industry Restraints
3 Contraceptives Market by Manufacturers
  1. 3.1 Global Contraceptives Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Contraceptives Sales by Manufacturers (2021-2026)
  3. 3.3 Global Contraceptives Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Contraceptives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Contraceptives Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Contraceptives Manufacturers, Product Type & Application
  7. 3.7 Global Contraceptives Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Contraceptives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Contraceptives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Contraceptives Tier 1, Tier 2, and Tier 3
4 Contraceptives Market by Type
  1. 4.1 Contraceptives Type Introduction
  2. 4.1.1 Pills
  3. 4.1.2 Injectable
  4. 4.1.3 Condoms
  5. 4.1.4 Vaginal Rings
  6. 4.1.5 IUDs
  7. 4.1.6 Subdermal Implants
  8. 4.1.7 Others
  9. 4.2 Global Contraceptives Sales by Type
  10. 4.2.1 Global Contraceptives Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Contraceptives Sales by Type (2021-2032)
  12. 4.2.3 Global Contraceptives Sales Market Share by Type (2021-2032)
  13. 4.3 Global Contraceptives Revenue by Type
  14. 4.3.1 Global Contraceptives Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Contraceptives Revenue by Type (2021-2032)
  16. 4.3.3 Global Contraceptives Revenue Market Share by Type (2021-2032)
5 Contraceptives Market by Application
  1. 5.1 Contraceptives Application Introduction
  2. 5.1.1 15–24 years
  3. 5.1.2 25–34 years
  4. 5.1.3 35–44 years
  5. 5.1.4 Above 44 years
  6. 5.2 Global Contraceptives Sales by Application
  7. 5.2.1 Global Contraceptives Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Contraceptives Sales by Application (2021-2032)
  9. 5.2.3 Global Contraceptives Sales Market Share by Application (2021-2032)
  10. 5.3 Global Contraceptives Revenue by Application
  11. 5.3.1 Global Contraceptives Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Contraceptives Revenue by Application (2021-2032)
  13. 5.3.3 Global Contraceptives Revenue Market Share by Application (2021-2032)
6 Global Contraceptives Sales by Region
  1. 6.1 Global Contraceptives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Contraceptives Sales by Region (2021-2032)
  3. 6.2.1 Global Contraceptives Sales by Region (2021-2026)
  4. 6.2.2 Global Contraceptives Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Contraceptives Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Contraceptives Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Contraceptives Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Contraceptives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Contraceptives Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Contraceptives Revenue by Region
  1. 7.1 Global Contraceptives Revenue by Region
  2. 7.1.1 Global Contraceptives Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Contraceptives Revenue by Region (2021-2026)
  4. 7.1.3 Global Contraceptives Revenue by Region (2027-2032)
  5. 7.1.4 Global Contraceptives Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Contraceptives Revenue (2021-2032)
  8. 7.2.2 North America Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Contraceptives Revenue (2021-2032)
  11. 7.3.2 Europe Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Contraceptives Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Contraceptives Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Contraceptives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bayer AG
  2. 8.1.1 Bayer AG Company Information
  3. 8.1.2 Bayer AG Business Overview
  4. 8.1.3 Bayer AG Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bayer AG Contraceptives Product Portfolio
  6. 8.1.5 Bayer AG Recent Developments
  7. 8.2 Pfizer, Inc
  8. 8.2.1 Pfizer, Inc Company Information
  9. 8.2.2 Pfizer, Inc Business Overview
  10. 8.2.3 Pfizer, Inc Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer, Inc Contraceptives Product Portfolio
  12. 8.2.5 Pfizer, Inc Recent Developments
  13. 8.3 Teva Pharmaceutical Industries Ltd
  14. 8.3.1 Teva Pharmaceutical Industries Ltd Company Information
  15. 8.3.2 Teva Pharmaceutical Industries Ltd Business Overview
  16. 8.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolio
  18. 8.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
  19. 8.4 Merck & Co., Inc
  20. 8.4.1 Merck & Co., Inc Company Information
  21. 8.4.2 Merck & Co., Inc Business Overview
  22. 8.4.3 Merck & Co., Inc Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co., Inc Contraceptives Product Portfolio
  24. 8.4.5 Merck & Co., Inc Recent Developments
  25. 8.5 Actavis, Inc.
  26. 8.5.1 Actavis, Inc. Company Information
  27. 8.5.2 Actavis, Inc. Business Overview
  28. 8.5.3 Actavis, Inc. Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Actavis, Inc. Contraceptives Product Portfolio
  30. 8.5.5 Actavis, Inc. Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson Contraceptives Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
  37. 8.7 Gedeon Richter
  38. 8.7.1 Gedeon Richter Company Information
  39. 8.7.2 Gedeon Richter Business Overview
  40. 8.7.3 Gedeon Richter Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gedeon Richter Contraceptives Product Portfolio
  42. 8.7.5 Gedeon Richter Recent Developments
  43. 8.8 Novo Nordisk A/S
  44. 8.8.1 Novo Nordisk A/S Company Information
  45. 8.8.2 Novo Nordisk A/S Business Overview
  46. 8.8.3 Novo Nordisk A/S Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novo Nordisk A/S Contraceptives Product Portfolio
  48. 8.8.5 Novo Nordisk A/S Recent Developments
  49. 8.9 ZiZhu
  50. 8.9.1 ZiZhu Company Information
  51. 8.9.2 ZiZhu Business Overview
  52. 8.9.3 ZiZhu Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 ZiZhu Contraceptives Product Portfolio
  54. 8.9.5 ZiZhu Recent Developments
  55. 8.10 Baijingyu
  56. 8.10.1 Baijingyu Company Information
  57. 8.10.2 Baijingyu Business Overview
  58. 8.10.3 Baijingyu Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Baijingyu Contraceptives Product Portfolio
  60. 8.10.5 Baijingyu Recent Developments
  61. 8.11 Huazhong
  62. 8.11.1 Huazhong Company Information
  63. 8.11.2 Huazhong Business Overview
  64. 8.11.3 Huazhong Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Huazhong Contraceptives Product Portfolio
  66. 8.11.5 Huazhong Recent Developments
  67. 8.12 Sine
  68. 8.12.1 Sine Company Information
  69. 8.12.2 Sine Business Overview
  70. 8.12.3 Sine Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sine Contraceptives Product Portfolio
  72. 8.12.5 Sine Recent Developments
  73. 8.13 Reckitt
  74. 8.13.1 Reckitt Company Information
  75. 8.13.2 Reckitt Business Overview
  76. 8.13.3 Reckitt Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Reckitt Contraceptives Product Portfolio
  78. 8.13.5 Reckitt Recent Developments
  79. 8.14 AbbVie
  80. 8.14.1 AbbVie Company Information
  81. 8.14.2 AbbVie Business Overview
  82. 8.14.3 AbbVie Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AbbVie Contraceptives Product Portfolio
  84. 8.14.5 AbbVie Recent Developments
  85. 8.15 Church & Dwight
  86. 8.15.1 Church & Dwight Company Information
  87. 8.15.2 Church & Dwight Business Overview
  88. 8.15.3 Church & Dwight Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Church & Dwight Contraceptives Product Portfolio
  90. 8.15.5 Church & Dwight Recent Developments
  91. 8.16 The Cooper Companies
  92. 8.16.1 The Cooper Companies Company Information
  93. 8.16.2 The Cooper Companies Business Overview
  94. 8.16.3 The Cooper Companies Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 The Cooper Companies Contraceptives Product Portfolio
  96. 8.16.5 The Cooper Companies Recent Developments
  97. 8.17 TherapeuticsMD
  98. 8.17.1 TherapeuticsMD Company Information
  99. 8.17.2 TherapeuticsMD Business Overview
  100. 8.17.3 TherapeuticsMD Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 TherapeuticsMD Contraceptives Product Portfolio
  102. 8.17.5 TherapeuticsMD Recent Developments
  103. 8.18 Afaxys
  104. 8.18.1 Afaxys Company Information
  105. 8.18.2 Afaxys Business Overview
  106. 8.18.3 Afaxys Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Afaxys Contraceptives Product Portfolio
  108. 8.18.5 Afaxys Recent Developments
  109. 8.19 Mithra Pharmaceuticals
  110. 8.19.1 Mithra Pharmaceuticals Company Information
  111. 8.19.2 Mithra Pharmaceuticals Business Overview
  112. 8.19.3 Mithra Pharmaceuticals Contraceptives Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Mithra Pharmaceuticals Contraceptives Product Portfolio
  114. 8.19.5 Mithra Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Contraceptives Value Chain Analysis
  2. 9.1.1 Contraceptives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Contraceptives Production Mode & Process
  6. 9.2 Contraceptives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Contraceptives Distributors
  9. 9.2.3 Contraceptives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst